Always a good sign when the top shareholder is buying more on market. Nice to see the Co give us clear guidelines to perceived commercialisation. I would think this would accelerate a lot faster on the back of RAP'S FDA approval.
MNQ Price at posting:
1.9¢ Sentiment: None Disclosure: Held
